Home Elixir Medical

Elixir Medical

Elixir Medical Corporation Announces Outstanding 5-Year Clinical Data for CE Mark-approved DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System

The company reports:  Excellent Six-Month Safety and Efficacy Results for Next-Generation Thin-strut DESolve® Cx Novolimus Eluting Bioresorbable Coronary Scaffold System also presented Elixir Medical Corporation, announced excellent 5-year clinical data from the DESolve Nx international pivotal clinical trial...

Elixir Medical to Release Five-year DESolve Nx Trial Data, Showcase Next-Generation Coronary and SFA Bioresorbable Scaffold Systems at EuroPCR 2017

Long-term 5-year clinical follow-up data for the DESolve® Novolimus eluting coronary scaffold system, 6-month clinical and imaging data for the 120 µm thin-strut DESolve™ Cx Novolimus eluting coronary bioresorbable scaffold system, and initial clinical results of the...